Investment Guru Stocks Mutual Funds Commodity Currency World Market Expert Advice Free Tips Recommendation


Published on 17/05/2018 5:45:16 PM | Source: Dion Global Solutions Ltd

Alembic Pharmaceutic Q4 net profit zooms 143.40% at Rs 144.19 cr

The company reported standalone net profit of Rs 144.19 crore for the quarter ended March 31, 2018 as compared to Rs 59.24 crore in the same period last year, registering a year-on-year growth of 143.40 per cent. Net revenue of the company rose substantially by 30.41 per cent at Rs 838.22 crore in January-March quarter of this fiscal as against Rs 642.75 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 15.88 per cent to Rs 631.43 crore from Rs 544.92 crore in year ago period.

Other Income dipped by 68.54 per cent at Rs 0.28 crore versus (Mar'17 Rs 0.89 crore). Operating Profit surged by 109.81 per cent to Rs 206.79 crore as against Rs 98.56 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 60.93 per cent in March quarter. Interest declined by 50.77 per cent y-o-y to Rs 0.64 crore, while Taxation increased by 100.94 per cent at Rs 34.32 crore (Mar'17 Rs 17.08 crore).